Products for Research Use Only
RegisterLogin

ZLDI-8

CAT: 0013-GTR19157301-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19157301-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ZLDI-8 is an inhibitor of Notch activating/cleaving enzyme ADAM-17 and inhibits the cleavage of Notch protein.ZLDI-8; it inhibited the cleavage of NOTCH protein, consequently decreased the expression of pro-survival/anti-apoptosis and EMT related proteins. ZLDI-8 treatment enhanced the susceptibility of HCC cells to a small molecular kinase inhibitor Sorafenib, and chemotherapy agents Etoposide and Paclitaxel. ZLDI-8 treatment enhanced the effect of Sorafenib on inhibiting tumor growth in nude HCC-bearing mice model. In nude HCC-bearing mice model, ZLDI-8 (0.2-2 mg/kg; intraperitoneal injection; every two days; for 20 days; nude mice) treatment enhances the effect of Sorafenib on inhibiting tumor growth.
CAS Number
667880-38-8
Purity
>98% (HPLC)
Solubility
DMSO:62.5 mg/mL (144.17 mM; Need ultrasonic)
Smiles
O=C (/C (C (N1) =O) =C/C2=C (C) N (CCOC3=CC=C (C) C=C3C) C4=C2C=CC=C4) NC1=S
Molecular Formula
C24H23N3O3S
Molecular Weight
433.52
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.

Related Products

CatalogName
GTR191822288,8''-Bibaicalein
GTR191798858,8''-Biskoenigine
GTR19236261-01YT-8-8
GTR19234928-01Nav1.8-IN-8
GTR19218787-01TLR7/8 agonist 8
GTR19351621-01(-) -8,8-Dichlorocampherylsulfonyl-oxaziridine
GTR19230843-01Aβ-IN-8
GTR19090156-01Recombinant Innexin-8 (inx-8)
GTR18985660Interleukin-8 (IL-8) Antigen
GTR19266204-017,8,7’,8’-Tetradehydroastaxanthin

Alternative Products

CatalogName
MBS5754166ZLDI-8
M31480-018,8-Bibaicalein
CUA89082-018,8''-Biskoenigine
TBZ00908,8'-Bieckol
sc-20020NCK2 (8.8)
HY-N8842-018,8''-Bibaicalein
HY-160589Nav1.8-IN-8
HY-161737-01YT-8-8
MBS393760-01Octanoic-8,8,8-D3 Acid
TRC-S960044-10MGSodium Octanoate-8,8,8-d3

Popular Products